The University of Southampton
University of Southampton Institutional Repository

Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia (review)

Dusse, Luci Maria, Cooper, Alan J. and Lwaleed, Bashir A. (2007) Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia (review) Clinica Chimica Acta, 378, (1-2), pp. 1-6. (doi:10.1016/j.cca.2006.10.014).

Record type: Article

Abstract

Pre-eclampsia (P-Ec) is a complex multisystem disorder of unknown aetiology reported to occur in about 6% to 8% of all pregnancies throughout the world. This disease is associated with fibrin deposition and occlusive lesions in placental vessels. Pro-thrombin activatable fibrinolysis inhibitor (pro-TAFI) is a relatively recently described glycoprotein that can be converted into its active form (TAFIa) by thrombin, thrombin–thrombomodulin and plasmin. TAFIa potentially inhibits fibrinolysis by removing C-terminal lysine and arginine residues from fibrin. These residues are required for adsorption of tissue-type plasminogen activator (t-PA) and plasminogen to fibrin. Therefore, TAFIa decreases plasmin formation and protects the fibrin clot against lysis. An increased of pro-TAFI/TAFIa levels has been reported in some clinical conditions associated with thrombotic tendency, as type II diabetes mellitus, deep vein thrombosis and symptomatic artery disease. Few studies have investigated pro-TAFI/TAFIa in normal or complicated pregnancy but contrasting results were reported. Understanding the role of pro-TAFI/TAFIa in the pathogenesis of P-Ec can hold great promise for improving P-Ec management. In this context, a large-scale study evaluating plasma TAFI antigen and activity, its synthesis and metabolism in pre-eclamptic women is required. Recently new selective TAFIa inhibitors have been developed. The design of a new therapy to treat and/or prevent P-Ec, based on successful use of TAFIa inhibitors, may have significant clinical ramifications

Full text not available from this repository.

More information

Published date: March 2007
Additional Information: Invited critical review
Keywords: pro-TAFI, TAFIa, pre-eclampsia

Identifiers

Local EPrints ID: 73032
URI: http://eprints.soton.ac.uk/id/eprint/73032
ISSN: 0009-8981
PURE UUID: a1676881-fa6f-4583-81da-38e02dc4cd8b

Catalogue record

Date deposited: 26 Feb 2010
Last modified: 18 Jul 2017 23:51

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×